Literature DB >> 18653581

Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation.

K Prasad1, L Williams, R Campbell, P M Elliott, W J McKenna, M Frenneaux.   

Abstract

Symptoms of impaired consciousness (syncope and pre-syncope) occur in 15-25% of patients with hypertrophic cardiomyopathy (HCM).1 In young patients a history of recurrent syncope is associated with an increased risk of sudden death.2(-)5 Syncope usually occurs without warning or symptoms suggestive of the cause. Detailed investigations identify a probable mechanism in a minority, usually paroxysmal atrial fibrillation or ventricular tachycardia. In the majority however no likely mechanism is found despite repeated 24-hour ambulatory echocardiography (ECG) or patient-activated monitoring, exercise testing and invasive electrophysiological studies.1 6 Empirical treatment with amiodarone, a pacemaker or an implantable cardioverter-defibrillator is commonly employed, but is often unsuccessful in relieving the symptoms. We have previously observed that approximately 30% of patients with HCM have abnormal blood pressure response during maximal upright exercise.7 8 This was due in the majority of patients to an exaggerated fall in systemic vascular resistance, possibly arising from abnormal activation of stretch-sensitive left ventricular mechanoreceptors,9 10 by a mechanism similar to that described in aortic stenosis.11 However, in some patients an inadequate cardiac output response to exercise may be responsible.12 We hypothesised that abnormal vasodepressor-mediated hypotension may also occur during daily life in patients with HCM, and that this may be an important mechanism of syncope when conventional investigations fail to reveal a cause.

Entities:  

Mesh:

Year:  2008        PMID: 18653581     DOI: 10.1136/hrt.2008.141507

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

1.  Exercise in hypertrophic cardiomyopathy.

Authors:  Sharlene M Day
Journal:  J Cardiovasc Transl Res       Date:  2009-10-14       Impact factor: 4.132

2.  Hypotension in hereditary cardiomyopathy.

Authors:  Johny Al-Khoury; Danielle Jacques; Ghassan Bkaily
Journal:  Pflugers Arch       Date:  2022-02-09       Impact factor: 3.657

Review 3.  Hypertrophic cardiomyopathy as a cause of sudden death.

Authors:  Hubert Seggewiss; Christoph Blank; Barbara Pfeiffer; Angelos Rigopoulos
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

4.  Orthostatic blood pressure test for risk stratification in patients with hypertrophic cardiomyopathy.

Authors:  Julia Münch; Ali Aydin; Anna Suling; Christian Voigt; Stefan Blankenberg; Monica Patten
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.